from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2345/-

LFCtreatmentdescriptionclass of inhibitor

-1.060

Amikacinug/mL Amikacintranslation

-1.163

Cap5-10ug/mL Capreomycintranslation

-1.949

Rox10-50 ug/mL Roxithromycintranslation

-0.422

SM2-5 ug/mL Streptomycintranslation

-1.629

Tet5-10 ug/mL Tetracyclinetranslation

-1.574

Rif0.2-5ug/mL Rifampicintranscription

-0.695

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.922

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.312

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.968

CPZ10-50 ug/mL Chlorpromazinerespiration

1.229

Clofazimine10-13 ug/mL Clofaziminerespiration

0.326

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.826

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.182

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.035

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.398

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.610

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.975

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.171

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.444

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.845

KCN5-20 ug/mL Potassium cyaniderespiration

1.086

NaN30.2-2 mM Sodium aziderespiration

0.085

Nigericin50 uM Nigericinrespiration

0.906

TRC10-150 ug/mL Triclosanrespiration

2.066

TRZ10-25 ug/mL Thioridazinerespiration

-1.323

Valinomycin0.5-10 uM Valinomycinrespiration

0.223

ZnSO42 mM ZnSO4respiration

0.298

menadione6-10 ug/mL Menadionerespiration

0.400

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.317

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.214

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.131

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.054

NRP_1Non-replicating persistence stage 1dosRassociated

-0.220

Amp0.2mg/mL AmpicillincellWall

0.060

Cephalexin20-100 ug/mL CephalexincellWall

-0.082

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.201

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.349

EMB10-20 ug/mL EthambutolcellWall

-0.269

Eta12-40 ug/mL EthionamidecellWall

-0.274

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.056

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.090

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.108

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.309

BZA0.12 mg/mL BenzamidearomaticAmides

-0.392

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.212

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.869

H2O24 mM hydrogen peroxideDNAdamaging

-0.587

Levo10 ug/mL LevofloxacinDNAdamaging

-0.636

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.354

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.265

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.774

UVUV-irradiationDNAdamaging

0.556

ARP41-4 ug/mL Antitubercular compound ARP4?

0.028

Antimycin12.5-50 ug/mL Antimycin A?

-0.341

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.273

PA_110-50 ug/mL Antitubercular compound PA-1?

0.119

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.431

PA8240.2-2 ug/mL PA-824?

0.638

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.023

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.119

Verapamil50 uM Verapamil?

0.004

mercaptoethanol2 mM 2-Mercaptoethanol?

0.305

methoxatin10-20 ug/mL Methoxatin?